Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04997603 · ClinicalTrials.gov registry record · NA

Sleep, Physical Activity, and Dietary Habits Among High School Student-athletes and Non-athletes During an Academic Semester

A NA study, sponsored by PepsiCo Global R&D.

Completed
Registry status
NA
Development phase
96
Enrollment target

NCT04997603: Completed NA study, sponsored by PepsiCo Global R&D.

NCT04997603 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04997603, a NA study, has completed, sponsored by PepsiCo Global R&D.

COMPLETED
Registry status
NA
Development phase
96 participants
Enrollment target

Study Summary

Adolescent's poor sleep habits have been linked to adverse outcomes. Recent advances in activity tracking have provided researchers with cost-effective and non-invasive measurements of sleep in a free-living environment. The primary objective is to determine the mean differences in Fitbit accelerometer sleep quantity (mins) between High School student-athletes and non-athletes during a competitive academic semester over continuous monitoring for two weeks.

Primary Outcome

Measured in minutes. More minutes are better.

Interventions

  • OTHER Accelerometer

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2020-10-16
Est. Completion 2020-12-20
Phase NA
PepsiCo Global R&D

47 total trials

What the finished NCT04997603 record still lists

NCT04997603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Accelerometer is the first listed.

NCT04997603 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04997603 about?

NCT04997603 is a clinical study titled "Sleep, Physical Activity, and Dietary Habits Among High School Student-athletes and Non-athletes During an Academic Semester". Adolescent's poor sleep habits have been linked to adverse outcomes. Recent advances in activity tracking have provided researchers with cost-effective and non-invasive measurements of sleep in a free-living environment. The primary objective is to determine the mean differences in Fitbit accelerome...

What is the current status of trial NCT04997603?

This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2020-10-16. Estimated completion is 2020-12-20.

What interventions are being tested in trial NCT04997603?

The interventions under investigation include: Accelerometer (OTHER).

Who is sponsoring clinical trial NCT04997603?

This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04997603's enrollment target sits among peer trials

96 925th of 2000 higher than 1,070 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04997603, the US trial registry maintained by the National Library of Medicine. NCT04997603 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.